The global NDDS market is currently worth $139 billion and is set to grow by almost 50% to $196.4 billion by 2014.” BCC Research, August 2009 According to a recent CPhI survey, 95% of Tier I pharmaceutical companies in India are currently investigating the NDDS market opportunity.
How are you positioning your organisation to manage the risks and reap the rewards of Novel Drug Delivery Systems?
Attend this 2-day technical strategy conference and uncover all the key challenges and opportunities that will enable you to drive the potential of NDDS in your organisation.
Don't miss your chance to Benefit from in-depth presentations on the key scientific advances in:
- NDDS Platforms & Technologies
- Transdermal Nanotechnology
- Oral drug delivery Injectables
- Inhalation NDDS Therapeutic Applications
Oncology CNS Diabetes Cardiovascular Respiratory Leverage the latest advances in ingredients, materials, devices, and safety & efficacy testing to drive innovation through your NDDS developments Learn the latest regulatory updates & IPR guidance to safeguard your NDDS investment.
For further details visit us at our web address
No comments:
Post a Comment